Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment

BACKGROUND: To evaluate the effect of systemic bevacizumab (Avastin®) therapy on pigment epithelial detachment (PED) secondary to age‐related macular degeneration (AMD) and to identify prognostic factors for PED regression and improvement in best corrected visual acuity (BCVA). STUDY DESIGN: Prospec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bolz, Matthias, Michels, Stephan, Geitzenauer, Wolfgang, Prager, Franz, Schmidt‐Erfurth, Ursula
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2007
Assuntos:
Extended Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2266832/
https://ncbi.nlm.nih.gov/pubmed/17050580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2006.102467
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados